Although many laboratories in Canada routinely perform PCR assays for the p210 transcript in CML from peripheral blood, optimal MRD testing for Ph-positive patients in ALL requires the use of bone marrow samples. This evidence concerns the gene EVPL and chronic myelogenous leukemia, BCR-ABL1 positive.